vs

Side-by-side financial comparison of Alpha Metallurgical Resources, Inc. (AMR) and Surgery Partners, Inc. (SGRY). Click either name above to swap in a different company.

Surgery Partners, Inc. is the larger business by last-quarter revenue ($885.0M vs $519.1M, roughly 1.7× Alpha Metallurgical Resources, Inc.). Surgery Partners, Inc. runs the higher net margin — -1.7% vs -3.3%, a 1.6% gap on every dollar of revenue. On growth, Surgery Partners, Inc. posted the faster year-over-year revenue change (2.4% vs -15.7%). Surgery Partners, Inc. produced more free cash flow last quarter ($90.6M vs $-10.0M). Over the past eight quarters, Surgery Partners, Inc.'s revenue compounded faster (11.1% CAGR vs -22.4%).

Alpha Metallurgical Resources, formerly Contura Energy, is a leading coal supplier with underground and surface coal mining complexes across Northern and Central Appalachia. Contura owns large coal basins in Pennsylvania, Virginia and West Virginia which supply both metallurgical coal to produce steel and thermal coal to generate power.

United Surgical Partners International, Inc. (USPI) is an American ambulatory care company based in Dallas, Texas. It was founded by Don Steen in 1998.

AMR vs SGRY — Head-to-Head

Bigger by revenue
SGRY
SGRY
1.7× larger
SGRY
$885.0M
$519.1M
AMR
Growing faster (revenue YoY)
SGRY
SGRY
+18.0% gap
SGRY
2.4%
-15.7%
AMR
Higher net margin
SGRY
SGRY
1.6% more per $
SGRY
-1.7%
-3.3%
AMR
More free cash flow
SGRY
SGRY
$100.6M more FCF
SGRY
$90.6M
$-10.0M
AMR
Faster 2-yr revenue CAGR
SGRY
SGRY
Annualised
SGRY
11.1%
-22.4%
AMR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMR
AMR
SGRY
SGRY
Revenue
$519.1M
$885.0M
Net Profit
$-17.3M
$-15.0M
Gross Margin
Operating Margin
-4.1%
12.5%
Net Margin
-3.3%
-1.7%
Revenue YoY
-15.7%
2.4%
Net Profit YoY
-711.2%
86.2%
EPS (diluted)
$-1.35
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMR
AMR
SGRY
SGRY
Q4 25
$519.1M
$885.0M
Q3 25
$525.2M
$821.5M
Q2 25
$548.7M
$826.2M
Q1 25
$529.7M
$776.0M
Q4 24
$615.4M
$864.4M
Q3 24
$669.8M
$770.4M
Q2 24
$800.1M
$762.1M
Q1 24
$861.3M
$717.4M
Net Profit
AMR
AMR
SGRY
SGRY
Q4 25
$-17.3M
$-15.0M
Q3 25
$-5.5M
$-22.7M
Q2 25
$-5.0M
$-2.5M
Q1 25
$-33.9M
$-37.7M
Q4 24
$-2.1M
$-108.5M
Q3 24
$3.8M
$-31.7M
Q2 24
$58.9M
$-15.5M
Q1 24
$127.0M
$-12.4M
Operating Margin
AMR
AMR
SGRY
SGRY
Q4 25
-4.1%
12.5%
Q3 25
-0.5%
12.9%
Q2 25
0.5%
13.5%
Q1 25
-7.6%
8.0%
Q4 24
1.6%
14.7%
Q3 24
0.8%
7.9%
Q2 24
8.8%
11.1%
Q1 24
16.5%
10.6%
Net Margin
AMR
AMR
SGRY
SGRY
Q4 25
-3.3%
-1.7%
Q3 25
-1.1%
-2.8%
Q2 25
-0.9%
-0.3%
Q1 25
-6.4%
-4.9%
Q4 24
-0.3%
-12.6%
Q3 24
0.6%
-4.1%
Q2 24
7.4%
-2.0%
Q1 24
14.7%
-1.7%
EPS (diluted)
AMR
AMR
SGRY
SGRY
Q4 25
$-1.35
$-0.11
Q3 25
$-0.42
$-0.18
Q2 25
$-0.38
$-0.02
Q1 25
$-2.60
$-0.30
Q4 24
$-0.09
$-0.86
Q3 24
$0.29
$-0.25
Q2 24
$4.49
$-0.12
Q1 24
$9.59
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMR
AMR
SGRY
SGRY
Cash + ST InvestmentsLiquidity on hand
$415.6M
$239.9M
Total DebtLower is stronger
$9.8M
$3.6B
Stockholders' EquityBook value
$1.5B
$1.7B
Total Assets
$2.3B
$8.1B
Debt / EquityLower = less leverage
0.01×
2.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMR
AMR
SGRY
SGRY
Q4 25
$415.6M
$239.9M
Q3 25
$457.9M
$203.4M
Q2 25
$449.0M
$250.1M
Q1 25
$448.0M
$229.3M
Q4 24
$481.6M
$269.5M
Q3 24
$484.6M
$221.8M
Q2 24
$336.1M
$213.5M
Q1 24
$269.4M
$185.2M
Total Debt
AMR
AMR
SGRY
SGRY
Q4 25
$9.8M
$3.6B
Q3 25
$2.9M
$3.5B
Q2 25
$3.1M
$3.5B
Q1 25
$2.4M
$3.4B
Q4 24
$2.9M
$3.3B
Q3 24
$3.6M
$3.1B
Q2 24
$5.3M
$3.0B
Q1 24
$6.0M
$2.8B
Stockholders' Equity
AMR
AMR
SGRY
SGRY
Q4 25
$1.5B
$1.7B
Q3 25
$1.6B
$1.7B
Q2 25
$1.6B
$1.7B
Q1 25
$1.6B
$1.7B
Q4 24
$1.6B
$1.8B
Q3 24
$1.7B
$1.9B
Q2 24
$1.6B
$2.0B
Q1 24
$1.6B
$2.0B
Total Assets
AMR
AMR
SGRY
SGRY
Q4 25
$2.3B
$8.1B
Q3 25
$2.3B
$7.9B
Q2 25
$2.4B
$8.0B
Q1 25
$2.4B
$7.9B
Q4 24
$2.4B
$7.9B
Q3 24
$2.5B
$7.5B
Q2 24
$2.5B
$7.5B
Q1 24
$2.5B
$7.0B
Debt / Equity
AMR
AMR
SGRY
SGRY
Q4 25
0.01×
2.10×
Q3 25
0.00×
2.00×
Q2 25
0.00×
1.98×
Q1 25
0.00×
1.98×
Q4 24
0.00×
1.83×
Q3 24
0.00×
1.63×
Q2 24
0.00×
1.56×
Q1 24
0.00×
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMR
AMR
SGRY
SGRY
Operating Cash FlowLast quarter
$19.0M
$103.4M
Free Cash FlowOCF − Capex
$-10.0M
$90.6M
FCF MarginFCF / Revenue
-1.9%
10.2%
Capex IntensityCapex / Revenue
5.6%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$17.8M
$195.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMR
AMR
SGRY
SGRY
Q4 25
$19.0M
$103.4M
Q3 25
$50.5M
$83.6M
Q2 25
$53.2M
$81.3M
Q1 25
$22.2M
$6.0M
Q4 24
$56.3M
$111.4M
Q3 24
$189.5M
$65.2M
Q2 24
$138.1M
$82.8M
Q1 24
$196.1M
$40.7M
Free Cash Flow
AMR
AMR
SGRY
SGRY
Q4 25
$-10.0M
$90.6M
Q3 25
$25.4M
$63.8M
Q2 25
$18.6M
$57.9M
Q1 25
$-16.3M
$-16.7M
Q4 24
$13.6M
$89.1M
Q3 24
$158.0M
$45.0M
Q2 24
$77.0M
$55.9M
Q1 24
$132.5M
$19.7M
FCF Margin
AMR
AMR
SGRY
SGRY
Q4 25
-1.9%
10.2%
Q3 25
4.8%
7.8%
Q2 25
3.4%
7.0%
Q1 25
-3.1%
-2.2%
Q4 24
2.2%
10.3%
Q3 24
23.6%
5.8%
Q2 24
9.6%
7.3%
Q1 24
15.4%
2.7%
Capex Intensity
AMR
AMR
SGRY
SGRY
Q4 25
5.6%
1.4%
Q3 25
4.8%
2.4%
Q2 25
6.3%
2.8%
Q1 25
7.3%
2.9%
Q4 24
6.9%
2.6%
Q3 24
4.7%
2.6%
Q2 24
7.6%
3.5%
Q1 24
7.4%
2.9%
Cash Conversion
AMR
AMR
SGRY
SGRY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
49.81×
Q2 24
2.34×
Q1 24
1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMR
AMR

Segment breakdown not available.

SGRY
SGRY

Private Insurance$460.5M52%
Government Revenue$368.6M42%
Other$19.8M2%
Self Pay Revenue$19.6M2%
Other Patient Service Revenue Sources$16.5M2%

Related Comparisons